Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Edetate Calcium Disodium,Sodium Citrate
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Approved FDF
Sponsor : Kane Biotech
Deal Size : Undisclosed
Deal Type : Agreement
Details : Under the agreement, ProgenaCare will commercialize coactiv+ (disodium EDTA) Antimicrobial Wound Gel in the U.S. wound care market. The coactiv+ is a combination of Kane’s patented coactiv+™ technology and PHMB, paired with a non-ionic pluronic surfa...
Product Name : Coactiv+
Product Type : Other Small Molecule
Upfront Cash : $0.5 million
April 20, 2023
Lead Product(s) : Edetate Calcium Disodium,Sodium Citrate
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Approved FDF
Sponsor : Kane Biotech
Deal Size : Undisclosed
Deal Type : Agreement
Lead Product(s) : Edetate Calcium Disodium,Sodium Citrate
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Approved FDF
Sponsor : Salud Pharma
Deal Size : Undisclosed
Deal Type : Agreement
Kane Biotech Announces First Distribution Agreement for its Coactiv+™ Antimicrobial Hydrogel
Details : The coactiv+™ (disodium EDTA) Antimicrobial Hydrogel is a combination of Kane’s patented coactiv+™ antibiofilm technology and PHMB in a thermo-reversible gel.
Product Name : Revye
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
April 01, 2023
Lead Product(s) : Edetate Calcium Disodium,Sodium Citrate
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Approved FDF
Sponsor : Salud Pharma
Deal Size : Undisclosed
Deal Type : Agreement
Lead Product(s) : Sodium Citrate
Therapeutic Area : Endocrinology
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 05, 2021
Lead Product(s) : Sodium Citrate
Therapeutic Area : Endocrinology
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable